IGF2BP3 and YTHDF3 are found to be the biomarkers for BLCA; METTL14 for CHOL; RBFOX2 for GBM and KIRP; RBM15B, TRMT112, and YTHDF2 for KIRP; FMR1 and METTL3 for LGG; YTHDC2 and ZCCHC4 for LUAD; ALKBH5, FMR1, HNRNPA2B1, YTHDC2, YTHDF2, and ZC3H13 for OV; and YTHDF2 for PCPG (Figure 8B). This evidence concerns the gene METTL3 and bladder transitional cell carcinoma.